<DOC>
	<DOCNO>NCT00124475</DOCNO>
	<brief_summary>The purpose study determine therapeutic effect alitretinoin , retinoid , severe , therapy refractory chronic hand dermatitis .</brief_summary>
	<brief_title>Efficacy Safety Retinoid Treatment Severe Chronic Hand Dermatitis</brief_title>
	<detailed_description>Chronic hand dermatitis ( CHaD ) frequent distress disease . Conventional treatment yield mostly unsatisfactory result . In addition , chronic hand dermatitis lead 2-5 % application permanent disability pension western country . In therapeutic dose find study alitretinoin clinically effective patient moderate severe chronic hand dermatitis refractory topical treatment . Patients severe refractory CHaD allocate either two active treatment placebo . The primary objective demonstrate response rate base physician global assessment disease .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<mesh_term>Hand Dermatoses</mesh_term>
	<mesh_term>Alitretinoin</mesh_term>
	<criteria>Chronic hand dermatitis , type include hyperkeratotic , vesicular , fingertip dermatitis Lasting 6 month since initial diagnosis Rated severe Refractory standard therapy include nonmedicated therapy avoidance irritant allergens Refractory topical steroid Female patient pregnant want become pregnant Female patient child bear potential use commit use two effective form contraception simultaneously Patients whose disease adequately control standard nonmedicated therapy standard corticosteroid therapy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Chronic Hand Dermatitis</keyword>
</DOC>